Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cadiz (CDZI) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Cadiz (CDZI) over the last 16 years, with Q3 2025 value amounting to $4.4 million.

  • Cadiz's Cash & Equivalents rose 3319.3% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 3319.3%. This contributed to the annual value of $17.3 million for FY2024, which is 28409.6% up from last year.
  • Latest data reveals that Cadiz reported Cash & Equivalents of $4.4 million as of Q3 2025, which was up 3319.3% from $13.2 million recorded in Q2 2025.
  • Cadiz's Cash & Equivalents' 5-year high stood at $26.3 million during Q1 2023, with a 5-year trough of $3.3 million in Q3 2024.
  • Moreover, its 5-year median value for Cash & Equivalents was $13.2 million (2022), whereas its average is $13.7 million.
  • Within the past 5 years, the most significant YoY rise in Cadiz's Cash & Equivalents was 28409.6% (2024), while the steepest drop was 7500.38% (2024).
  • Quarter analysis of 5 years shows Cadiz's Cash & Equivalents stood at $11.0 million in 2021, then decreased by 8.83% to $10.0 million in 2022, then plummeted by 54.97% to $4.5 million in 2023, then skyrocketed by 284.1% to $17.3 million in 2024, then crashed by 74.38% to $4.4 million in 2025.
  • Its Cash & Equivalents was $4.4 million in Q3 2025, compared to $13.2 million in Q2 2025 and $21.6 million in Q1 2025.